Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 5.866% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCC(=O)N(Cc1ccco1)Cc1cc2cc3c(cc2[nH]c1=O)OCO3
b.) Cc1c(OC(C)C(=O)NCCN2CCOCC2)ccc2c3c(c(=O)oc12)CCCC3
c.) N=c1c2c(-c3ccccc3)c(-c3ccccc3)n(Cc3ccco3)c2ncn1CCO
Answer: b. Cc1c(OC(C)C(=O)NCCN2CCOCC2)ccc2c3c(c(=O)oc12)CCCC3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1c(OC(C)C(=O)NCCN2CCOCC2)ccc2c3c(c(=O)oc12)CCCC3
Cc1c(OC(C)C(=O)NCCN2CCOCC2)ccc2c3c(c(=O)oc12)CCCC3
2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]-N-(2-morpholin-4-ylethyl)propanamide